STUDY OBJECTIVES: To compare the efficacy of continuous radiofrequency (CRF) thermocoagulation with pulsed radiofrequency (PRF) in the treatment of lumbar facet syndrome. DESIGN: Prospective, randomized, double-blinded study. SETTING:Ambulatory pain clinic at a level-I trauma center and teaching institution. PATIENTS: 50 ASA physical statusI, II, and III patients, at least 18 years of age, scheduled to undergo CRF or PRF for lumbar back pain. INTERVENTIONS: Target facet joints were identified with oblique radiographic views. Continuous radiofrequency thermocoagulation was delivered at 80 degrees C for 75 seconds, while PRF was delivered at 42 degrees C with a pulse duration of 20 ms and pulse rate of two Hz for 120 seconds. MEASUREMENTS: Visual analog scale (VAS) pain assessment and Oswestry LowBack Pain and Disability Questionnaire (OSW) were administered at baseline and then at three months. Comparisons between groups and within groups were made of the relative percentage improvement in VAS and OSW scores. MAIN RESULTS: No significant differences in the relative percentage improvement were noted between groups in either VAS (P = 0.46) or OSW scores (P = 0.35). Within the PRF group, comparisons of the relative change over time for both VAS (P = 0.21) and OSW scores (P = 0.61) were not significant. However, within the CRF group, VAS (P = 0.02) and OSW scores (P = 0.03) showed significant improvement. CONCLUSIONS: Although there was no significant difference between CRF and PRF therapy in long-term outcome in the treatment of lumbar facet syndrome, there was a greater improvement over time noted within the CRF group.
RCT Entities:
STUDY OBJECTIVES: To compare the efficacy of continuous radiofrequency (CRF) thermocoagulation with pulsed radiofrequency (PRF) in the treatment of lumbar facet syndrome. DESIGN: Prospective, randomized, double-blinded study. SETTING: Ambulatory pain clinic at a level-I trauma center and teaching institution. PATIENTS: 50 ASA physical status I, II, and III patients, at least 18 years of age, scheduled to undergo CRF or PRF for lumbar back pain. INTERVENTIONS: Target facet joints were identified with oblique radiographic views. Continuous radiofrequency thermocoagulation was delivered at 80 degrees C for 75 seconds, while PRF was delivered at 42 degrees C with a pulse duration of 20 ms and pulse rate of two Hz for 120 seconds. MEASUREMENTS: Visual analog scale (VAS) pain assessment and Oswestry Low Back Pain and Disability Questionnaire (OSW) were administered at baseline and then at three months. Comparisons between groups and within groups were made of the relative percentage improvement in VAS and OSW scores. MAIN RESULTS: No significant differences in the relative percentage improvement were noted between groups in either VAS (P = 0.46) or OSW scores (P = 0.35). Within the PRF group, comparisons of the relative change over time for both VAS (P = 0.21) and OSW scores (P = 0.61) were not significant. However, within the CRF group, VAS (P = 0.02) and OSW scores (P = 0.03) showed significant improvement. CONCLUSIONS: Although there was no significant difference between CRF and PRF therapy in long-term outcome in the treatment of lumbar facet syndrome, there was a greater improvement over time noted within the CRF group.
Authors: Rudolf Likar; Johann Auer; Albert Chavanne; Wilfried Ilias; Michael Kern; Petra Krepler; Hans-Georg Kress; Ulrike Lischnig; Gernot Maurer; Oliver Sommer; Martin C Spendel; Siegfried Thurnher; Karl Wohak; Andreas Wolf; Michael Wölkhart Journal: Schmerz Date: 2021-01-14 Impact factor: 1.107
Authors: Danielle M Perret; Doo-Sik Kim; Kang-Wu Li; Karin Sinavsky; Robert L Newcomb; Jason M Miller; Z David Luo Journal: Anesth Analg Date: 2011-05-19 Impact factor: 5.108
Authors: Steven P Cohen; Arun Bhaskar; Anuj Bhatia; Asokumar Buvanendran; Tim Deer; Shuchita Garg; W Michael Hooten; Robert W Hurley; David J Kennedy; Brian C McLean; Jee Youn Moon; Samer Narouze; Sanjog Pangarkar; David Anthony Provenzano; Richard Rauck; B Todd Sitzman; Matthew Smuck; Jan van Zundert; Kevin Vorenkamp; Mark S Wallace; Zirong Zhao Journal: Reg Anesth Pain Med Date: 2020-04-03 Impact factor: 6.288